Sector News

Nestlé Health Science to buy majority stake in nutrition company Orgain

February 4, 2022
Food & Drink

Nestlé Health Science has agreed to purchase a majority stake in functional nutrition company, Orgain, from founder and CEO Andrew Abraham and Butterfly Equity.

Following the deal, Abraham and private equity firm Butterfly will retain “significant” minority ownership positions in the company, which makes nutritional products, most of which are certified organic.

Integrative medicine specialist Abraham – who will continue to lead Orgain as CEO – founded the business in 2009. The company’s portfolio includes protein powders, meal replacement shakes and snack bars for adults and children.

“Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges,” said Greg Behar, CEO of Nestlé Health Science.

“Orgain’s emphasis on clean, all-natural, plant-based, organic ingredients has made it a leader in the US, and we look forward to combining our companies’ expertise to bring Orgain to more people around the world.”

Butterfly, alongside Ontario Teachers’ Pension Plan Board and DCP Capital, acquired a majority stake in Orgain in 2019. Ontario Teachers’ and DCP Capital will also retain minority holdings in the company.

Butterfly co-founder, Dustin Beck, said: “It’s been inspiring to watch Andrew help pioneer the clean nutrition movement. He’s a visionary in the space and his drive and passion, along with that of the entire Orgain organisation, have created a truly remarkable business.

“We’re excited to see what they will be able to accomplish in this next chapter of the clean nutrition movement alongside the perfect partner.”

The agreement includes the option for Nestlé Health Science to fully acquire Orgain in 2024.

The financial terms of the deal have not been disclosed.

By Antonia Garrett Peel


comments closed

Related News

May 21, 2022

Cécile Béliot becomes Bel Group CEO

Food & Drink

Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.

May 21, 2022

“Corporate greed and dereliction of duty”: FDA commissioner slammed over infant formula shortage

Food & Drink

US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.

May 21, 2022

Sweegen hails antioxidants and bitter blocking tech a turning point for sugar reduction and healthy aging

Food & Drink

Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.